REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/18/2026
Back to search
Official data from USPTO
PSR ORPHAN EXPERTS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
05/19/2026
Trademark type
Combined
Nice classes
5, 35, 42, 44
Filing date
06/17/2019
Registration date
05/18/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/18/2021
Last transaction
05/19/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
3
Owner type
99
Owner location
Hoofddorp, NL
Examiner
FICKES, JERI J
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the dark blue letters "PSR" above the words "ORPHAN" in red and "EXPERTS" in dark blue, all in stylized font and to the right of a dark blue circle with three cutaway isosceles trapezoids in the colors red, dark blue, and light blue; all against a contrasting background shown in white, which is not being claimed as a color and is intended only to show background.
Holders and representatives
Holders
PSR Group B.V.
Representatives
Kevin S. Costanza SEED IP LAW GROUP LLP
Technical classification
Nice Classes
Class 5Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of orphan diseases
Class 35
Database managementpersonnel recruitmentall in the field of pharmaceutical drugs for treating orphan diseases
Class 42
Scientific research in the field of pharmaceutical drugs for treating orphan diseases and pharmaceutical drugs; pharmaceutical drug developmentincluding development of pharmaceutical preparations to treat orphan diseases
Class 44
Medical and pharmaceutical advisory and consultancy services related to the use in medical care of pharmaceutical drugs for treating orphan diseases
Publications
History of USPTO decisions and trademark events.
28 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/18/2021
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
04/12/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/06/2021
IUCN
NOTICE OF ALLOWANCE CANCELLED
01/04/2021
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
01/04/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/29/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/03/2020
PUBO
PUBLISHED FOR OPPOSITION
11/03/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/14/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/29/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/25/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/24/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/24/2020
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
03/24/2020
GPRA
PRIORITY ACTION E-MAILED
03/24/2020
CPRA
PRIORITY ACTION WRITTEN
03/24/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/24/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/24/2020
ALIE
ASSIGNED TO LIE
02/20/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/13/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/11/2019
GNRT
NON-FINAL ACTION E-MAILED
09/11/2019
CNRT
NON-FINAL ACTION WRITTEN
09/11/2019
DOCK
ASSIGNED TO EXAMINER
09/08/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/28/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/27/2019
NWAP
NEW APPLICATION ENTERED
06/20/2019
Continuous trademark protection
Get notified about every new filing that threatens PSR ORPHAN EXPERTS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.